Lloyd Inc. of Iowa is recalling 12,168 units of various veterinary thyroid medications, specifically Levothyroxine sodium tablets (0.2 mg, 0.3 mg, 0.7 mg, 0.8 mg, and 1.0 mg) sold under brands including LLOYD Thyro-Tabs, Butler Schein Thyroxine L, Phoenix Thyrozine, and VEDCO Thyrosyn. These medications were recalled because they failed to meet quality release and in-process specifications, meaning the potency or stability of the drug may be compromised. These products were distributed nationwide in 120-count, 180-count, and 1,000-count bottles.
The tablets failed to meet finished product and in-process specifications, which can lead to the medication being less effective or having inconsistent dosages. This may cause inadequate treatment of thyroid conditions in animals.
Return product to pharmacist or contact healthcare provider.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response